{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:18:56Z","timestamp":1762273136331,"version":"3.41.2"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Bioprosthetic mitral valves on average have a median durability between 8 and 10 years. After the failure of a bioprosthetic valve, surgical replacement is often indicated. However, the options for those patients at high or prohibitive surgical risks are limited. Here, we describe a case of a successful trans-catheter mitral valve-in-valve (TMViV) replacement on venoarterial extracorporeal membrane oxygenation (VA-ECMO).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We describe a case of a 39-year-old female with a history notable for systemic lupus erythematosus, severe pulmonary arterial hypertension (now mixed pre and post) thought to be secondary to prior substance use, and infective endocarditis complicated by severe mitral stenosis status post-bioprosthetic mitral valve replacement who presented with symptoms of acute hypoxic respiratory failure secondary to severe bioprosthetic mitral valve stenosis. The patient had a prolonged hospital course complicated by a pulseless electrical activity arrest, (continuous renal replacement therapy) for acute renal failure, and hypertonic saline due to cerebral oedema. Due to her significant co-morbidities and haemodynamic instability with acute kidney injury and recent neurologic insult, the patient was thought not to be a good surgical candidate. However, given her young age and overall improved neurologic status, it was thought the patient could benefit from a TMViV with bi-ventricular support given her right- and left-sided heart failure and was placed on VA-ECMO in anticipation of a TMViV procedure for circulatory support. The patient underwent a successful TMViV replacement using a trans-septal approach with a 26\u2005mm SAPIEN 3 valve and atrial septal defect closure with a 14\u2005mm Amplatzer device on hospital Day 12. The patient was successfully de-cannulated from VA-ECMO on hospital Day 13. The patient had a prolonged hospital course but eventually had renal recovery and tracheostomy de-cannulation. A trans-thoracic echocardiogram prior to discharge was notable for a well-functioning valve and normal ejection fraction. The patient was discharged to a nursing home for further rehabilitation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The gold standard for bioprosthetic mitral valve stenosis is surgical replacement of the valve. However, the options for those at high or prohibitive surgical risk are lacking. Recent studies have demonstrated TMViV is a safe alternative to surgical mitral valve redo cases in high-risk patients. To our knowledge, there are limited data on trans-catheter valve placement while on VA-ECMO. Successful implantation in our patient suggests that TMViV in a stenotic bioprosthesis is feasible in very high-risk patients with the use of VA-ECMO to support haemodynamics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytad427","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:28:03Z","timestamp":1693582083000},"source":"Crossref","is-referenced-by-count":3,"title":["Trans-catheter mitral valve-in-valve replacement in a patient on venoarterial extracorporeal membrane oxygenation: a case report"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1685-5455","authenticated-orcid":false,"given":"Jassimran Singh","family":"Bainiwal","sequence":"first","affiliation":[{"name":"Department of Medicine, UCLA Medical Center , Los Angeles, CA 90095 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy-Ann","family":"Ham","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine at UCLA , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olcay","family":"Aksoy","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, UCLA Medical Center , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"2023091408321832700_ytad427-B1","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2017.02.045","article-title":"Transcatheter mitral valve replacement: insights from early clinical experience and future challenges","volume":"69","author":"Regueiro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023091408321832700_ytad427-B2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mtc.2001.116470","article-title":"Repeat heart valve surgery: risk factors for operative mortality","volume":"122","author":"Jones","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023091408321832700_ytad427-B3","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.3949\/ccjm.83.s2.02","article-title":"Transcatheter mitral valve replacement: a frontier in cardiac intervention","volume":"83","author":"Krishnaswamy","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"2023091408321832700_ytad427-B4","doi-asserted-by":"crossref","first-page":"e019854","DOI":"10.1161\/JAHA.120.019854","article-title":"Reoperative mitral surgery versus transcatheter mitral valve replacement: a systematic review","volume":"10","author":"Sengupta","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2023091408321832700_ytad427-B5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jcin.2018.03.011","article-title":"Comparison of clinical and echocardiographic outcomes after surgical redo mitral valve replacement and transcatheter mitral valve-in-valve therapy","volume":"11","author":"Kamioka","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2023091408321832700_ytad427-B6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jocs.13767","article-title":"Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: a systematic review and meta-analysis","volume":"33","author":"Hu","year":"2018","journal-title":"J Card Surg"},{"key":"2023091408321832700_ytad427-B7","first-page":"268","article-title":"Clipping severe functional mitral regurgitation in a failing heart under extracorporeal membrane oxygenation support","volume":"36","author":"Lee","year":"2020","journal-title":"Acta Cardiol Sin"},{"key":"2023091408321832700_ytad427-B8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fcvm.2019.00174","article-title":"Percutaneous trans-septal mitral valve-in-ring implantation using a transcatheter balloon-expandable transcatheter heart valve with elective intra-procedural artero-venous ECMO in a patient with severely reduced left ventricular ejection fraction","volume":"6","author":"Ristalli","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2023091408321832700_ytad427-B9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaccas.2022.02.017","article-title":"Extracorporeal membrane oxygenation-supported transcatheter mitral valve-in-valve replacement and paravalvular plugging for critical prosthetic mitral stenosis","volume":"4","author":"Meredith","year":"2022","journal-title":"JACC Case Rep"},{"key":"2023091408321832700_ytad427-B10","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1161\/CIRCULATIONAHA.110.011973","article-title":"Reoperation of left heart valve bioprostheses according to age at implantation","volume":"124","author":"Chan","year":"2011","journal-title":"Circulation"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytad427\/51328642\/ytad427.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/9\/ytad427\/51550061\/ytad427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/9\/ytad427\/51550061\/ytad427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:47:06Z","timestamp":1694702826000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytad427\/7258414"}},"subtitle":[],"editor":[{"given":"Krishnaraj","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Annagrazia","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Athithan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytad427","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,9,1]]},"article-number":"ytad427"}}